---
source: https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla
date: 2025-06-24
type: Company
---

# Abridge Raises $300M Series E at $5.3B Valuation

Abridge, an AI startup automating medical notes, secured a $300 million Series E at a $5.3 billion valuation.

## Key Details

- **Funding:** $300M Series E led by Andreessen Horowitz with Khosla Ventures participation
- **Valuation:** $5.3B (doubled from $2.75B in February 2025)
- **Total Raised:** $800M+ since 2018
- **ARR:** $117M contracted ARR in Q1 2025
- **Customers:** 150+ health systems (50% increase in 4 months)

## Product

Abridge's technology uses AI to convert patient-clinician conversations into structured clinical note drafts in real time, integrating seamlessly with EHR systems. The company leverages a proprietary dataset from 1.5 million+ medical encounters.

## Expansion

The company will use funds to expand into AI-powered medical coding, in addition to scaling its core medical scribe technology.

## Market Position

Abridge is widely considered the leader in the AI-powered medical scribe market, largely due to early entry and integration with Epic Systems.
